Illinois Enacts New Law Allowing Pharmacists to Prescribe PHEXXI Contraceptive from 2026

A New Era in Contraceptive Access in Illinois

On August 15, 2025, the state of Illinois made significant strides toward improving contraceptive access with the enactment of House Bill 3489. This pivotal legislation empowers pharmacists to prescribe a broader range of contraceptives, including the innovative hormone-free PHEXXI® (lactic acid, citric acid, and potassium bitartrate), produced by Evofem Biosciences. This change is set to take effect on January 1, 2026.

Addressing a Critical Need

The introduction of House Bill 3489 is a response to the pressing demand for diverse contraceptive options among women in Illinois. Recognizing that many women have varied healthcare needs and preferences when it comes to contraception, this law not only facilitates access but also promotes informed choices by providing a mix of hormonal and non-hormonal contraceptives. As Saundra Pelletier, CEO of Evofem, articulated, this law is crucial in ensuring women across the state have quick access to methods that suit their individual health needs.

What is PHEXXI?

PHEXXI® stands out as the first and only hormone-free, on-demand prescription contraceptive vaginal gel. Unlike traditional contraceptives that require daily intake or other consistent application methods, PHEXXI is a user-friendly option that is applied just prior to intercourse. Esteemed for its convenience, it also has the advantage of minimizing interaction with other medications.

Notably, PHEXXI maintains efficacy regardless of the user’s body mass index (BMI), making it accessible to a wider demographic of women. Furthermore, clinical trials, including the pivotal Phase 3 AMPOWER trial, have shown that this innovative gel not only prevents pregnancy effectively but also contributes to increased sexual satisfaction, adding to its appeal.

Legislative Background

House Bill 3489 was championed by Illinois State Representative Michelle Mussman and supported by Chief Senate Sponsor Senator Rachael Ventura. With the passage of this law, Illinois joins 30 other states and the District of Columbia in allowing pharmacists to prescribe contraceptives, marking a concerted move towards expanding access to reproductive healthcare.

Implications for Women's Health

The enactment of this law signifies a major milestone in women's reproductive rights and health in Illinois. Women now have greater autonomy in choosing their contraceptive methods, and with pharmacists stepping into the role of prescribers, it is expected that they will provide necessary guidance and counseling to women seeking contraceptive solutions. This change not only enhances access but also aims to reduce the barriers many women face in obtaining timely reproductive healthcare.

How Women Can Access PHEXXI

In addition to being prescribed by pharmacists, women interested in PHEXXI can visit the official website, phexxi.com, to learn more about the product, connect with healthcare providers, and, if desired, obtain a prescription. This accessibility can lead to more informed decisions and healthier outcomes for women across the state.

Conclusion

As we stand on the brink of this new opportunity in 2026, the implementation of House Bill 3489 is set to empower women in Illinois significantly. By broadening access to non-hormonal contraceptives like PHEXXI, this legislation not only enhances reproductive autonomy but also addresses a vital health need among women. The ripple effects of this change could resonate beyond state lines, inspiring similar legislative movements across the nation, potentially reshaping the landscape of reproductive healthcare.

For more information about PHEXXI and its implications, please consult with healthcare providers or visit Evofem Biosciences.